Skip to main content
SpringerLink
Log in

Immune checkpoint inhibitor-related risk of pulmonary AEs

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis BMC Medicine 22: 19 Feb 2024. Available from: URL: https://doi.org/10.1186/s12916-024-03285-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Immune checkpoint inhibitor-related risk of pulmonary AEs. Reactions Weekly 1997, 12 (2024). https://doi.org/10.1007/s40278-024-53693-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-53693-9

Search

Navigation